Immutep Cost Of Revenue vs Income Tax Expense Analysis

IMMP Stock

USD 2.92 0.10 3.55%

Immutep financial indicator trend analysis is infinitely more than just investigating Immutep Ltd ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immutep Ltd ADR is a good investment. Please check the relationship between Immutep Cost Of Revenue and its Income Tax Expense accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Cost Of Revenue vs Income Tax Expense

Cost Of Revenue vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immutep Ltd ADR Cost Of Revenue account and Income Tax Expense. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Immutep's Cost Of Revenue and Income Tax Expense is -0.44. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Immutep Ltd ADR, assuming nothing else is changed. The correlation between historical values of Immutep's Cost Of Revenue and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Immutep Ltd ADR are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Cost Of Revenue i.e., Immutep's Cost Of Revenue and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

-0.44

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Immutep Ltd ADR income statement and represents the costs associated with goods and services Immutep provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Income Tax Expense

Most indicators from Immutep's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immutep Ltd ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At this time, Immutep's Issuance Of Capital Stock is relatively stable compared to the past year. As of 05/17/2024, Enterprise Value is likely to grow to about 2.6 B, while Selling General Administrative is likely to drop slightly above 9.3 M.

	2021	2023	2024 (projected)
Reconciled Depreciation	3.0M	3.4M	2.3M
Net Interest Income	192.0K	1.1M	1.1M

Reconciled Depreciation Net Interest Income

Immutep fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Short Long Term Debt Total	Short Term Debt	Non Currrent Assets Other	Non Current Liabilities Total	Other Liab	Common Stock
Total Assets		0.93	0.96	1.0	0.24	-0.97	-0.74	0.9	0.99	0.13	0.99	0.91	0.94	-0.21	0.68	0.05	0.37	0.84	0.99	0.04	-0.29	-0.34	0.45	-0.22	-0.2	0.98
Other Current Liab	0.93		0.92	0.91	0.07	-0.89	-0.81	0.8	0.91	0.2	0.9	0.97	0.93	-0.36	0.78	0.15	0.56	0.67	0.92	0.12	-0.08	-0.49	0.33	0.01	0.05	0.93
Total Current Liabilities	0.96	0.92		0.95	0.33	-0.91	-0.68	0.96	0.94	0.11	0.95	0.88	0.89	-0.14	0.66	0.04	0.41	0.85	0.95	0.02	-0.28	-0.18	0.3	-0.2	-0.1	0.93
Total Stockholder Equity	1.0	0.91	0.95		0.28	-0.97	-0.69	0.9	1.0	0.09	0.99	0.89	0.93	-0.2	0.68	0.07	0.3	0.86	0.99	-0.01	-0.35	-0.3	0.5	-0.29	-0.26	0.97
Property Plant And Equipment Net	0.24	0.07	0.33	0.28		-0.34	0.12	0.5	0.28	-0.57	0.35	0.06	0.18	0.1	0.2	0.17	-0.29	0.67	0.33	-0.62	-0.54	0.68	0.37	-0.63	-0.5	0.13
Net Debt	-0.97	-0.89	-0.91	-0.97	-0.34		0.69	-0.86	-0.98	-0.02	-0.97	-0.88	-0.93	0.25	-0.7	-0.07	-0.27	-0.86	-0.98	0.09	0.4	0.29	-0.55	0.33	0.29	-0.94
Retained Earnings	-0.74	-0.81	-0.68	-0.69	0.12	0.69		-0.52	-0.69	-0.59	-0.64	-0.84	-0.77	0.32	-0.6	0.17	-0.79	-0.38	-0.66	-0.53	-0.33	0.65	-0.02	-0.39	-0.24	-0.79
Accounts Payable	0.9	0.8	0.96	0.9	0.5	-0.86	-0.52		0.89	-0.07	0.92	0.76	0.8	0.05	0.51	0.03	0.26	0.92	0.91	-0.16	-0.38	0.0	0.36	-0.33	-0.21	0.84
Cash	0.99	0.91	0.94	1.0	0.28	-0.98	-0.69	0.89		0.06	0.99	0.9	0.94	-0.2	0.67	0.03	0.3	0.86	0.99	-0.04	-0.34	-0.33	0.51	-0.28	-0.25	0.98
Non Current Assets Total	0.13	0.2	0.11	0.09	-0.57	-0.02	-0.59	-0.07	0.06		-0.02	0.21	0.12	-0.12	0.07	-0.44	0.66	-0.29	0.0	0.99	0.55	-0.52	-0.55	0.64	0.5	0.22
Cash And Short Term Investments	0.99	0.9	0.95	0.99	0.35	-0.97	-0.64	0.92	0.99	-0.02		0.87	0.92	-0.18	0.67	0.12	0.25	0.89	1.0	-0.12	-0.39	-0.25	0.55	-0.33	-0.3	0.95
Net Receivables	0.91	0.97	0.88	0.89	0.06	-0.88	-0.84	0.76	0.9	0.21	0.87		0.96	-0.38	0.76	0.0	0.55	0.67	0.89	0.13	-0.07	-0.53	0.3	0.03	0.04	0.94
Common Stock Shares Outstanding	0.94	0.93	0.89	0.93	0.18	-0.93	-0.77	0.8	0.94	0.12	0.92	0.96		-0.35	0.74	0.01	0.41	0.77	0.93	0.03	-0.21	-0.43	0.41	-0.14	-0.16	0.97
Inventory	-0.21	-0.36	-0.14	-0.2	0.1	0.25	0.32	0.05	-0.2	-0.12	-0.18	-0.38	-0.35		-0.82	-0.33	-0.16	0.04	-0.19	-0.11	0.03	0.29	-0.16	-0.04	-0.08	-0.25
Other Current Assets	0.68	0.78	0.66	0.68	0.2	-0.7	-0.6	0.51	0.67	0.07	0.67	0.76	0.74	-0.82		0.33	0.32	0.48	0.68	0.01	-0.18	-0.29	0.36	-0.11	-0.04	0.69
Other Stockholder Equity	0.05	0.15	0.04	0.07	0.17	-0.07	0.17	0.03	0.03	-0.44	0.12	0.0	0.01	-0.33	0.33		-0.18	0.05	0.11	-0.44	-0.19	0.16	0.38	-0.24	-0.21	-0.06
Total Liab	0.37	0.56	0.41	0.3	-0.29	-0.27	-0.79	0.26	0.3	0.66	0.25	0.55	0.41	-0.16	0.32	-0.18		-0.01	0.28	0.62	0.69	-0.6	-0.43	0.77	0.69	0.42
Property Plant And Equipment Gross	0.84	0.67	0.85	0.86	0.67	-0.86	-0.38	0.92	0.86	-0.29	0.89	0.67	0.77	0.04	0.48	0.05	-0.01		0.88	-0.37	-0.58	0.13	0.56	-0.57	-0.49	0.77
Total Current Assets	0.99	0.92	0.95	0.99	0.33	-0.98	-0.66	0.91	0.99	0.0	1.0	0.89	0.93	-0.19	0.68	0.11	0.28	0.88		-0.1	-0.37	-0.27	0.53	-0.31	-0.27	0.96
Intangible Assets	0.04	0.12	0.02	-0.01	-0.62	0.09	-0.53	-0.16	-0.04	0.99	-0.12	0.13	0.03	-0.11	0.01	-0.44	0.62	-0.37	-0.1		0.6	-0.49	-0.6	0.68	0.53	0.13
Short Long Term Debt Total	-0.29	-0.08	-0.28	-0.35	-0.54	0.4	-0.33	-0.38	-0.34	0.55	-0.39	-0.07	-0.21	0.03	-0.18	-0.19	0.69	-0.58	-0.37	0.6		-0.48	-0.62	0.97	0.69	-0.21
Short Term Debt	-0.34	-0.49	-0.18	-0.3	0.68	0.29	0.65	0.0	-0.33	-0.52	-0.25	-0.53	-0.43	0.29	-0.29	0.16	-0.6	0.13	-0.27	-0.49	-0.48		-0.05	-0.57	-0.35	-0.45
Non Currrent Assets Other	0.45	0.33	0.3	0.5	0.37	-0.55	-0.02	0.36	0.51	-0.55	0.55	0.3	0.41	-0.16	0.36	0.38	-0.43	0.56	0.53	-0.6	-0.62	-0.05		-0.67	-0.74	0.39
Non Current Liabilities Total	-0.22	0.01	-0.2	-0.29	-0.63	0.33	-0.39	-0.33	-0.28	0.64	-0.33	0.03	-0.14	-0.04	-0.11	-0.24	0.77	-0.57	-0.31	0.68	0.97	-0.57	-0.67		0.82	-0.12
Other Liab	-0.2	0.05	-0.1	-0.26	-0.5	0.29	-0.24	-0.21	-0.25	0.5	-0.3	0.04	-0.16	-0.08	-0.04	-0.21	0.69	-0.49	-0.27	0.53	0.69	-0.35	-0.74	0.82		-0.14
Common Stock	0.98	0.93	0.93	0.97	0.13	-0.94	-0.79	0.84	0.98	0.22	0.95	0.94	0.97	-0.25	0.69	-0.06	0.42	0.77	0.96	0.13	-0.21	-0.45	0.39	-0.12	-0.14

Click cells to compare fundamentals

Immutep Account Relationship Matchups

Immutep fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	46.6M	82.0M	102.2M	147.4M	169.6M	178.0M
Other Current Liab	1.6M	3.3M	3.4M	4.1M	4.8M	5.0M
Total Current Liabilities	3.4M	5.3M	6.4M	9.8M	11.2M	11.8M
Total Stockholder Equity	33.3M	73.3M	94.1M	136.5M	156.9M	164.8M
Property Plant And Equipment Net	250.6K	309.7K	308.1K	468.5K	538.8K	270.3K
Net Debt	(17.3M)	(57.3M)	(78.3M)	(122.2M)	(110.0M)	(104.5M)
Retained Earnings	(275.7M)	(274.6M)	(302.3M)	(339.9M)	(305.9M)	(290.6M)
Accounts Payable	1.6M	1.8M	2.9M	5.4M	6.3M	6.6M
Cash	26.3M	60.1M	80.0M	123.4M	141.9M	149.0M
Non Current Assets Total	15.4M	13.6M	11.4M	12.5M	14.4M	10.9M
Cash And Short Term Investments	26.3M	60.1M	80.0M	123.4M	141.9M	149.0M
Net Receivables	3.4M	6.1M	8.4M	8.0M	9.2M	9.6M
Common Stock Shares Outstanding	407.3M	604.3M	862.3M	892.4M	1.0B	1.1B
Liabilities And Stockholders Equity	46.6M	82.0M	102.2M	147.4M	169.6M	178.0M
Other Current Assets	1.4M	7.8M	3.6M	3.6M	4.1M	4.3M
Other Stockholder Equity	33.3M	73.3M	38.7M	39.8M	35.8M	38.9M
Total Liab	13.3M	8.8M	8.1M	11.0M	12.6M	7.5M
Property Plant And Equipment Gross	250.6K	309.7K	941.1K	1.1M	1.3M	1.3M
Total Current Assets	31.2M	68.4M	90.8M	135.0M	155.2M	163.0M
Accumulated Other Comprehensive Income	66.0M	34.5M	29.0M	30.1M	34.6M	29.0M
Intangible Assets	15.1M	12.7M	10.4M	9.4M	10.8M	10.1M
Short Long Term Debt Total	9.1M	2.8M	1.7M	1.2M	1.4M	1.3M
Short Term Debt	129.4K	208.2K	173.4K	185.2K	166.7K	228.7K
Non Currrent Assets Other	(15.4M)	454.2K	495.7K	2.5M	2.9M	3.0M
Non Current Liabilities Total	9.9M	3.4M	1.7M	1.2M	1.4M	1.3M
Other Liab	1.0M	811.9K	117.3K	164.4K	189.1K	179.6K
Common Stock	243.0M	313.4M	367.4M	446.3M	513.2M	538.9M
Property Plant Equipment	250.6K	309.7K	308.1K	468.5K	421.7K	227.9K
Common Stock Total Equity	213.2M	221.1M	233.3M	313.4M	360.4M	225.2M
Net Tangible Assets	18.1M	60.4M	83.5M	127.0M	146.0M	153.3M
Long Term Debt	8.8M	2.5M	2.1M	835.4K	751.9K	714.3K
Capital Lease Obligations	262.4K	288.3K	408.3K	392.8K	451.7K	474.3K
Net Invested Capital	42.1M	75.8M	138.9M	137.3M	157.9M	165.8M
Net Working Capital	27.8M	63.1M	122.7M	125.2M	144.0M	151.2M
Capital Stock	243.0M	313.4M	534.1M	446.3M	513.2M	386.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Immutep Ltd ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Immutep Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Immutep Ltd Adr Stock. Highlighted below are key reports to facilitate an investment decision about Immutep Ltd Adr Stock:

How To Invest In Immutep

Details

Is Immutep Stock a good investment?

Details

What is Immutep's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Immutep Stock analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.

	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum

Is Immutep's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immutep. If investors know Immutep will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immutep listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.28)

Revenue Per Share

0.04

Quarterly Revenue Growth

0.252

Return On Assets

(0.26)

Return On Equity

(0.42)

The market value of Immutep Ltd ADR is measured differently than its book value, which is the value of Immutep that is recorded on the company's balance sheet. Investors also form their own opinion of Immutep's value that differs from its market value or its book value, called intrinsic value, which is Immutep's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immutep's market value can be influenced by many factors that don't directly affect Immutep's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immutep Cost Of Revenue vs Income Tax Expense Analysis

Cost Of Revenue vs Income Tax Expense

Cost Of Revenue vs Income Tax Expense Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Income Tax Expense

Immutep fundamental ratios Correlations

Immutep Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immutep fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Immutep Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets

Total Current Assets	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Cash And Short Term Investments	- 0.97	Net Debt
Net Debt	- 0.97	Total Stockholder Equity
Net Debt	- 0.97	Total Assets
Common Stock	- 0.94	Net Debt